FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107

Resources that use this resource

Resources that this resource uses

Narrative

No narrative content found in resource

Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.11.1107",
  "meta": {
    "versionId": "40",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2023-02-11"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.110.11.1107"
    }
  ],
  "version": "20230211",
  "name": "VaricellaZosterVaccineVZVAdministered",
  "title": "Varicella Zoster Vaccine (VZV) Administered",
  "status": "active",
  "date": "2023-02-11T01:02:55-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for a varicella zoster vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a varicella zoster vaccination.),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "425897001",
            "display": "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
          },
          {
            "code": "428502009",
            "display": "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
          },
          {
            "code": "432636005",
            "display": "Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
          },
          {
            "code": "433733003",
            "display": "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
          },
          {
            "code": "572511000119105",
            "display": "Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure)"
          },
          {
            "code": "737081007",
            "display": "Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
          },
          {
            "code": "871898007",
            "display": "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (procedure)"
          },
          {
            "code": "871899004",
            "display": "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route (procedure)"
          },
          {
            "code": "871909005",
            "display": "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:949ce4b6-7c3b-4054-9f70-4b6e0f864edf",
    "timestamp": "2025-05-23T22:16:06-04:00",
    "total": 9,
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "425897001",
        "display": "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "428502009",
        "display": "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "432636005",
        "display": "Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "433733003",
        "display": "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "572511000119105",
        "display": "Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "737081007",
        "display": "Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "871898007",
        "display": "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "871899004",
        "display": "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "871909005",
        "display": "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
      }
    ]
  }
}